Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (отвара нови прозор)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Извор‎: J Bone Joint Surg Am 2013;95(21):1969-74.

Индекс‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (отвара нови прозор)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (отвара нови прозор)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Извор‎: J Bone Joint Surg Am 2013;95(21):1961-8.

Индекс‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (отвара нови прозор)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (отвара нови прозор)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Извор‎: Ann Surg 2019;269(5):794-804.

Индекс‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (отвара нови прозор)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (отвара нови прозор)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Извор‎: Spine 2009;34(19):2096-103.

Индекс‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (отвара нови прозор)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (отвара нови прозор)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

Извор‎: J Orthop Surg 2017;25(1):2309499016684725.

Индекс‎: PubMed 28176599

DOI‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (отвара нови прозор)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (отвара нови прозор)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Извор‎: J Arthroplasty 2013;28(8 Suppl):74-7.

Индекс‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (отвара нови прозор)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (отвара нови прозор)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Извор‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Индекс‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (отвара нови прозор)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (отвара нови прозор)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Извор‎: J Knee Surg 2017;30(5):460-6.

Индекс‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (отвара нови прозор)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (отвара нови прозор)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Извор‎: J Arthroplasty 2017;32(8):2375-80.

Индекс‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (отвара нови прозор)

Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (отвара нови прозор)

DiBlasi JF, Smith RP, Garavaglia J, Quedado J, Frye BM, Dietz MJ.

Извор‎: Am J Orthop 2016;45(7):E439-43.

Индекс‎: PubMed 28005108

https://www.ncbi.nlm.nih.gov/pubmed/28005108 (отвара нови прозор)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (отвара нови прозор)

Dobosz B, Dutka J, Dutka L, Maleta P.

Извор‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

Индекс‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (отвара нови прозор)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (отвара нови прозор)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Извор‎: Spine J 2017;17(7):977-82.

Индекс‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (отвара нови прозор)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (отвара нови прозор)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Извор‎: Orthop Clin North Am 2017;48(2):109-15.

Индекс‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (отвара нови прозор)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (отвара нови прозор)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Извор‎: Ir Med J 2018;111(4):730.

Индекс‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (отвара нови прозор)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (отвара нови прозор)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

Извор‎: Anesth Analg 2022;135(3):576-85.

Индекс‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (отвара нови прозор)

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (отвара нови прозор)

Frank SM, Wasey JO, Dwyer IM, Gokaslan ZL, Ness PM, Kebaish KM.

Извор‎: J Orthop Surg Res 2014;9:50.

Индекс‎: PubMed 24997589

DOI‎: 10.1186/s13018-014-0050-2

https://www.ncbi.nlm.nih.gov/pubmed/24997589 (отвара нови прозор)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (отвара нови прозор)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Извор‎: J Shoulder Elbow Surg 2016;25(4):614-8.

Индекс‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (отвара нови прозор)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (отвара нови прозор)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Извор‎: Transfusion 2017;57(2):357-66.

Индекс‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (отвара нови прозор)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (отвара нови прозор)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

Извор‎: J Arthroplasty 2013;28(8 Suppl):137-9.

Индекс‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (отвара нови прозор)

Cell saver for adult spinal deformity surgery reduces cost. (отвара нови прозор)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Извор‎: Spine Deform 2017;5(4):272-6.

Индекс‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (отвара нови прозор)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (отвара нови прозор)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Извор‎: J Am Acad Orthop Surg 2021;29(22):961-9.

Индекс‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (отвара нови прозор)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (отвара нови прозор)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Извор‎: Orthopedics 2017;40(6):e1044-9.

Индекс‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (отвара нови прозор)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (отвара нови прозор)

Harris RN, Moskal JT, Capps SG.

Извор‎: J Arthroplasty 2015;30(2):192-5.

Индекс‎: PubMed 25534861

DOI‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (отвара нови прозор)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (отвара нови прозор)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Извор‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Индекс‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (отвара нови прозор)

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (отвара нови прозор)

Karayiannis PN, Agus A, Bryce L, Hill JC, Beverland D.

Извор‎: Bone Jt Open 2022;3(7):536-42.

Индекс‎: PubMed 35816170

DOI‎: 10.1302/2633-1462.37.BJO-2021-0213.R1

https://www.ncbi.nlm.nih.gov/pubmed/35816170 (отвара нови прозор)

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (отвара нови прозор)

Kotzé A, Carter LA, Scally AJ.

Извор‎: Br J Anaesth 2012;108(6):943-52.

Индекс‎: PubMed 22593128

DOI‎: 10.1093/bja/aes135

https://www.ncbi.nlm.nih.gov/pubmed/22593128 (отвара нови прозор)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (отвара нови прозор)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Извор‎: Transfusion 2017;57(6):1347-58.

Индекс‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (отвара нови прозор)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (отвара нови прозор)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

Извор‎: Br J Anaesth 2007;99(6):794-800.

Индекс‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (отвара нови прозор)

A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (отвара нови прозор)

Mehra A, Murray J, DeAlwis C.

Извор‎: Ann R Coll Surg Engl 2004;86(4):260-2.

Индекс‎: PubMed 15239867

DOI‎: 10.1308/147870804551

https://www.ncbi.nlm.nih.gov/pubmed/15239867 (отвара нови прозор)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (отвара нови прозор)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

Извор‎: J Arthroplasty 2018;33(6):1705-12.

Индекс‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (отвара нови прозор)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (отвара нови прозор)

Moskal JT, Harris RN, Capps SG.

Извор‎: J Arthroplasty 2015;30(3):365-8.

Индекс‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (отвара нови прозор)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (отвара нови прозор)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

Извор‎: Blood Transfus 2013;11(2):260-71.

Индекс‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (отвара нови прозор)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (отвара нови прозор)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Извор‎: Blood Transfus 2014;12(1):40-9.

Индекс‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (отвара нови прозор)

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. (отвара нови прозор)

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

Извор‎: Transfusion 2011;51(1):118-24.

Индекс‎: PubMed 20624257

DOI‎: 10.1111/j.1537-2995.2010.02783.x

https://www.ncbi.nlm.nih.gov/pubmed/20624257 (отвара нови прозор)

Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. (отвара нови прозор)

Nichols CI, Vose JG.

Извор‎: J Arthroplasty 2016;31(3):583-589.e1.

Индекс‎: PubMed 26699673

DOI‎: 10.1016/j.arth.2015.10.013

https://www.ncbi.nlm.nih.gov/pubmed/26699673 (отвара нови прозор)

The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (отвара нови прозор)

Örs Ç, Çaylak R.

Извор‎: Acta Orthop Traumatol Turc 2021;55(5):422-7.

Индекс‎: PubMed 34730529

DOI‎: 10.5152/j.aott.2021.20397

https://www.ncbi.nlm.nih.gov/pubmed/34730529 (отвара нови прозор)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (отвара нови прозор)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

Извор‎: Open Orthop J 2011;5:44-8.

Индекс‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (отвара нови прозор)

ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (отвара нови прозор)

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J.

Извор‎: Anesth Analg 2022;135(3):448-58.

Индекс‎: PubMed 35977355

DOI‎: 10.1213/ANE.0000000000006065

https://www.ncbi.nlm.nih.gov/pubmed/35977355 (отвара нови прозор)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (отвара нови прозор)

Phan DL, Ani F, Schwarzkopf R.

Извор‎: J Arthroplasty 2016;31(3):579-82.

Индекс‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (отвара нови прозор)

Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (отвара нови прозор)

Pitta M, Zawadsky M, Verstraete R, Rubinstein A.

Извор‎: Transfusion 2016;56(2):466-71.

Индекс‎: PubMed 26509250

DOI‎: 10.1111/trf.13354

https://www.ncbi.nlm.nih.gov/pubmed/26509250 (отвара нови прозор)

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (отвара нови прозор)

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

Извор‎: BMJ 2014;349:g4829.

Индекс‎: PubMed 25116268

DOI‎: 10.1136/bmj.g4829

https://www.ncbi.nlm.nih.gov/pubmed/25116268 (отвара нови прозор)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (отвара нови прозор)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Извор‎: Clin Orthop Relat Res 2010;468(7):1905-11.

Индекс‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (отвара нови прозор)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (отвара нови прозор)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Извор‎: J Arthroplasty 2018;33(7):2092-9.e9.

Индекс‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (отвара нови прозор)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (отвара нови прозор)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

Извор‎: Transfus Med 2009;19(4):202-6.

Индекс‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (отвара нови прозор)

Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (отвара нови прозор)

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D'Amato T.

Извор‎: Int Orthop 2019;43(1):39-46.

Индекс‎: PubMed 30232527

DOI‎: 10.1007/s00264-018-4149-7

https://www.ncbi.nlm.nih.gov/pubmed/30232527 (отвара нови прозор)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (отвара нови прозор)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Извор‎: Int Orthop 2019;43(12):2707-14.

Индекс‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (отвара нови прозор)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (отвара нови прозор)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

Извор‎: J Orthop Surg Res 2011;6:22.

Индекс‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (отвара нови прозор)

Increased hospital costs associated with red blood cell transfusion. (отвара нови прозор)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Извор‎: Transfusion 2015;55(5):1082-9.

Индекс‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (отвара нови прозор)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (отвара нови прозор)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Извор‎: J Arthroplasty 2014;29(8):1512-5.

Индекс‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (отвара нови прозор)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (отвара нови прозор)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Извор‎: J Arthroplasty 2020;35(11):3084-8.

Индекс‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (отвара нови прозор)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (отвара нови прозор)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

Извор‎: Thromb Res 2018;171:143-8.

Индекс‎: PubMed 30312799

DOI‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (отвара нови прозор)

Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (отвара нови прозор)

Ye X, Lafuma A, Torreton E, Arnaud A.

Извор‎: BMC Health Serv Res 2013;13:186.

Индекс‎: PubMed 23692862

DOI‎: 10.1186/1472-6963-13-186

https://www.ncbi.nlm.nih.gov/pubmed/23692862 (отвара нови прозор)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (отвара нови прозор)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

Извор‎: Int Orthop 2007;31(3):303-8.

Индекс‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (отвара нови прозор)

Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (отвара нови прозор)

Zhu J, Zhu Y, Lei P, Zeng M, Su W, Hu Y.

Извор‎: Medicine 2017;96(52):e9552.

Индекс‎: PubMed 29384974

DOI‎: 10.1097/MD.0000000000009552

https://www.ncbi.nlm.nih.gov/pubmed/29384974 (отвара нови прозор)